CD33
Subscribe to
our newsletters!
Showing the single result
- This report provides an overview of CD33-targeted antibody and cell therapies in development for treatment of acute myeloid leukemia (AML)€ 150.00
Menu
Biopharma R&D Information
&
Custom Report Preparation
La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. We publish proprietary reports and prepare custom reports.